---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-022197"
form_type: "8-K"
ticker: null
cik: "0001522860"
company_name: "Acutus Medical, Inc."
filed_at: "2024-05-09T23:59:59+00:00"
generated_at: "2026-06-02T05:42:20.781624+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Acutus Medical Q1 revenue up 192% to $3.6M; net loss narrows; stock delisted to OTC Pink

## Summary
- Q1 continuing ops revenue $3.6M, up 192% YoY; GAAP gross margin improved to -1% from -70%.
- Net loss from continuing ops $2.1M ($0.07/share) vs $4.3M ($0.15) in Q1 2023.
- Cash, equivalents, marketable securities, restricted cash $20.0M at March 31, 2024.
- Nasdaq commenced delisting; stock now trades on OTC Pink under AFIB as of May 9, 2024.
- Company will cease providing financial guidance due to restructuring and exit from EP mapping/ablation.

## SEC filing metadata
- accession: 0001628280-24-022197
- form_type: 8-K
- cik: 0001522860
- company_name: Acutus Medical, Inc.
- filed_at: 2024-05-09T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1522860/000162828024022197/0001628280-24-022197-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1522860/000162828024022197/afib-20240509.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-022197
- JSON: https://secwatch.observer/filing/0001628280-24-022197.json
- Plain text: https://secwatch.observer/filing/0001628280-24-022197.txt

## Key facts
- Earnings Releases
  Acutus Medical, Inc. reported the quarter ended March 31, 2024 results: revenue $3.6 million, net income $2.1 million, EPS $0.07.
  - Period: the quarter ended March 31, 2024
  - Revenue: $3.6 million
  - Net income: $2.1 million
  - EPS: $0.07
  - Result: reported results
  source text: Inc. (“Acutus” or the “Company”) (OTC: AFIB) today reported results for the first quarter of 2024. Recent Highlights: • First quarter revenue from Continuing Operations of $3.6 million grew 192% year-over-year, from $1.2 million in the same quarter last year. • Operating expenses for continuing operations were $3.3 million, a reduction of 38% compared to the
  evidence_url: https://www.sec.gov/Archives/edgar/data/1522860/000162828024022197/0001628280-24-022197-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.